piperacillin has been researched along with virginiamycin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lindmark, A; Nord, CE; Persson, I | 1 |
| Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
| Hidai, H | 1 |
1 review(s) available for piperacillin and virginiamycin
| Article | Year |
|---|---|
[Antibiotics--TAZ/PIPC, synercid, linezolid, everninomicin].
Topics: Acetamides; Adult; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Drug Combinations; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Linezolid; Oxazolidinones; Penicillanic Acid; Penicillins; Piperacillin; Protein Synthesis Inhibitors; Tazobactam; Virginiamycin | 2001 |
2 other study(ies) available for piperacillin and virginiamycin
| Article | Year |
|---|---|
Susceptibility of anaerobic bacteria to the new streptogramin RP 59500 in vitro.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides; Cefoxitin; Chloramphenicol; Clostridium perfringens; Imipenem; Microbial Sensitivity Tests; Piperacillin; Species Specificity; Virginiamycin | 1989 |
Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactam.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Drug Combinations; Drug Therapy, Combination; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Spectinomycin; Tazobactam; Thienamycins; Virginiamycin | 1993 |